当前位置:首页 - 行情中心 - 申联生物(688098) - 财务分析 - 现金流量表

申联生物

(688098)

  

流通市值:36.63亿  总市值:36.63亿
流通股本:4.11亿   总股本:4.11亿

现金流量表

报告期2026-03-312025-12-312025-09-302025-06-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金41,392,811.53264,488,020.21146,597,121.0574,767,697.97
  收到其他与经营活动有关的现金3,720,845.5614,454,629.5813,216,306.4310,580,357.57
  经营活动现金流入小计45,113,657.09278,942,649.79159,813,427.4885,348,055.54
  购买商品、接受劳务支付的现金20,145,578.2263,631,869.6839,621,687.2426,721,310.98
  支付给职工以及为职工支付的现金24,021,273.9775,551,783.2859,830,942.1143,725,024.41
  支付的各项税费3,435,951.7312,230,589.959,544,113.966,461,858.11
  支付其他与经营活动有关的现金37,585,659.7294,451,565.3468,922,778.2947,828,915.52
  经营活动现金流出小计85,188,463.64245,865,808.25177,919,521.6124,737,109.02
  经营活动产生的现金流量净额-40,074,806.5533,076,841.54-18,106,094.12-39,389,053.48
二、投资活动产生的现金流量:
  收回投资收到的现金177,538,951.36590,000,000476,000,000352,000,000
  取得投资收益收到的现金293,986.13,552,514.73914,545.51679,898.91
  处置固定资产、无形资产和其他长期资产收回的现金净额-517,000517,0007,000
  投资活动现金流入小计177,832,937.46594,069,514.73477,431,545.51352,686,898.91
  购建固定资产、无形资产和其他长期资产支付的现金6,516,789.5445,233,904.9734,279,805.2121,658,558.85
  投资支付的现金171,000,000598,000,000459,500,000347,500,000
  投资活动现金流出小计177,516,789.54643,233,904.97493,779,805.21369,158,558.85
  投资活动产生的现金流量净额316,147.92-49,164,390.24-16,348,259.7-16,471,659.94
三、筹资活动产生的现金流量:
  收到其他与筹资活动有关的现金-16,317.3816,317.3816,317.38
  筹资活动现金流入平衡项目-000
  筹资活动现金流入小计-16,317.3816,317.3816,317.38
  偿还债务支付的现金-1,120,000560,000560,000
  分配股利、利润或偿付利息支付的现金62,790265,689.67202,202135,226
  支付其他与筹资活动有关的现金98,4132,136,887.392,008,660.952,016,651.58
  筹资活动现金流出小计161,2033,522,577.062,770,862.952,711,877.58
  筹资活动产生的现金流量净额-161,203-3,506,259.68-2,754,545.57-2,695,560.2
四、汇率变动对现金及现金等价物的影响-23.13-33.72-17.51-6.29
五、现金及现金等价物净增加额-39,919,884.76-19,593,842.1-37,208,916.9-58,556,279.91
  加:期初现金及现金等价物余额91,575,251.7111,169,093.8111,169,093.8111,169,093.8
  期末现金及现金等价物余额51,655,366.9491,575,251.773,960,176.952,612,813.89
补充资料:
  净利润--24,971,591.4--15,042,391.78
  资产减值准备--6,259.52--12,977.32
  固定资产和投资性房地产折旧-64,028,971.82-31,639,949.28
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-64,028,971.82-31,639,949.28
  无形资产摊销-10,999,425.83-4,860,951.56
  处置固定资产、无形资产和其他长期资产的损失--260,766.69-46,839.3
  固定资产报废损失-43,224.45--
  公允价值变动损失--2,402,823.06--2,157,584.14
  财务费用-580,993.74-162,689.33
  投资损失-3,004,545.84--42,443.37
  递延所得税--1,363,130.4--1,243,546.3
  其中:递延所得税资产减少--1,213,951.03--1,563,058.77
    递延所得税负债增加--149,179.37-319,512.47
  存货的减少-635,434.24--1,345,091.91
  经营性应收项目的减少--34,224,762.95--27,898,980.31
  经营性应付项目的增加-3,291,653.75--33,110,378.82
  现金的期末余额-91,575,251.7-52,612,813.89
  减:现金的期初余额-111,169,093.8-111,169,093.8
  现金及现金等价物的净增加额--19,593,842.1--58,556,279.91
公告日期2026-04-292026-04-292025-10-272025-08-30
审计意见(境内)标准无保留意见
TOP↑